Ezekiel E Young1, Christopher T Brown2, Paul A Merguerian3, Ardavan Akhavan4. 1. James Buchanan Brady Urological Institute, Johns Hopkins Children's Center, Baltimore, MD. Electronic address: eyoung31@alumni.jh.edu. 2. The University of Arizona College of Medicine, Department of Surgery, Section of Urology, Tucson, AZ. 3. Division of Pediatric Urology, Seattle Children's Hospital, Seattle, WA. 4. James Buchanan Brady Urological Institute, Johns Hopkins Children's Center, Baltimore, MD.
Abstract
OBJECTIVE: Renal cell carcinoma (RCC) is an uncommon malignancy among children and adolescents. Because of this, there has been relatively sparse research and evidence on the topic. As the body of research regarding pediatric and adolescent RCC has developed in recent years, it has become increasingly clear that it demonstrates important differences from the much more common adult-type RCC. This review aims to examine and summarize the current literature, with a focus on the ways that pediatric and adolescent RCC differ from the adult disease, and to make recommendations for evaluation and management based on this evidence whenever possible. METHODS AND MATERIALS: A thorough search of all articles relating to pediatric and adolescent RCC has been undertaken using PubMed. The reference lists from all relevant articles have been further reviewed, to ensure inclusion of all pertinent literature. CONCLUSION: The most significant development in recent years has been the realization that most of the pediatric and adolescent RCC cases, but only a very small fraction of adult RCC cases, demonstrate "translocation tumor" pathology. It is likely that such differences may eventually explain many of the previous observations regarding differences in behavior of RCC among children and teenagers. At this point, however, the relevance of translocation pathology to clinical management remains unclear, and so most continue to treat these patients in much the same way as those with the more conventional tumor subtypes.
OBJECTIVE:Renal cell carcinoma (RCC) is an uncommon malignancy among children and adolescents. Because of this, there has been relatively sparse research and evidence on the topic. As the body of research regarding pediatric and adolescent RCC has developed in recent years, it has become increasingly clear that it demonstrates important differences from the much more common adult-type RCC. This review aims to examine and summarize the current literature, with a focus on the ways that pediatric and adolescent RCC differ from the adult disease, and to make recommendations for evaluation and management based on this evidence whenever possible. METHODS AND MATERIALS: A thorough search of all articles relating to pediatric and adolescent RCC has been undertaken using PubMed. The reference lists from all relevant articles have been further reviewed, to ensure inclusion of all pertinent literature. CONCLUSION: The most significant development in recent years has been the realization that most of the pediatric and adolescent RCC cases, but only a very small fraction of adult RCC cases, demonstrate "translocation tumor" pathology. It is likely that such differences may eventually explain many of the previous observations regarding differences in behavior of RCC among children and teenagers. At this point, however, the relevance of translocation pathology to clinical management remains unclear, and so most continue to treat these patients in much the same way as those with the more conventional tumor subtypes.
Authors: Camilla Calandrini; Frans Schutgens; Rurika Oka; Thanasis Margaritis; Tito Candelli; Luka Mathijsen; Carola Ammerlaan; Ravian L van Ineveld; Sepide Derakhshan; Sanne de Haan; Emmy Dolman; Philip Lijnzaad; Lars Custers; Harry Begthel; Hindrik H D Kerstens; Lindy L Visser; Maarten Rookmaaker; Marianne Verhaar; Godelieve A M Tytgat; Patrick Kemmeren; Ronald R de Krijger; Reem Al-Saadi; Kathy Pritchard-Jones; Marcel Kool; Anne C Rios; Marry M van den Heuvel-Eibrink; Jan J Molenaar; Ruben van Boxtel; Frank C P Holstege; Hans Clevers; Jarno Drost Journal: Nat Commun Date: 2020-03-11 Impact factor: 14.919
Authors: Samara L Potter; Rajkumar Venkatramani; Scott Wenderfer; Brett H Graham; Sanjeev A Vasudevan; Andrew Sher; Hao Wu; David A Wheeler; Yaping Yang; Christine M Eng; Richard A Gibbs; Angshumoy Roy; Sharon E Plon; D Williams Parsons Journal: Pediatr Blood Cancer Date: 2016-10-17 Impact factor: 3.167
Authors: Kayo Nakata; Murielle Colombet; Charles A Stiller; Kathy Pritchard-Jones; Eva Steliarova-Foucher Journal: Int J Cancer Date: 2020-07-22 Impact factor: 7.316